* Objective: * A Randomized, Two-Way Crossover, Single-Dose, Open-Label Study to Evaluate the Bioequivalence of a Test Tablet Formulation of Metformin HCl (1000 mg), Compared to an Equivalent Dose of a Commercially Available Reference Drug Product (Glucophage®, Bristol-Myers Squibb Company) in Fasted, Healthy, Adult Subjects. * Study Design: * Randomized,single-dose,2-way crossover.
Study Type
INTERVENTIONAL
Gateway Medical Research, Inc.
Saint Charles, Missouri, United States
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.